TNFSF10 and neoplasm: CS-NG is equipped with an acid-degradable modality, and therefore it effectively releases combinatorially delivered cilengitide (antiangiogenic agent) and TRAIL to endothelial cells at the acidic tumour microenvironment and membrane of cancer cells respectively.